Investors Research Corp’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8K Buy
+300
New +$16.3K ﹤0.01% 512
2024
Q3
Sell
-21
Closed -$1.62K 986
2024
Q2
$1.62K Hold
21
﹤0.01% 948
2024
Q1
$1.44K Sell
21
-309
-94% -$19.9K ﹤0.01% 933
2023
Q4
$19.1K Buy
330
+309
+1,471% +$16.5K ﹤0.01% 643
2023
Q3
$1.11K Buy
+21
New +$1.1K ﹤0.01% 987
2023
Q1
Sell
-650
Closed -$30.1K 1131
2022
Q4
$30.1K Hold
650
0.01% 599
2022
Q3
$25K Hold
650
0.01% 600
2022
Q2
$24K Hold
650
0.01% 615
2022
Q1
$29K Hold
650
0.01% 593
2021
Q4
$28K Hold
650
0.01% 605
2021
Q3
$28K Hold
650
0.01% 613
2021
Q2
$28K Hold
650
0.01% 616
2021
Q1
$25K Hold
650
0.01% 639
2020
Q4
$23K Hold
650
0.01% 695
2020
Q3
$25K Hold
650
0.01% 632
2020
Q2
$23K Hold
650
0.01% 645
2020
Q1
$21K Hold
650
0.01% 600
2019
Q4
$29K Hold
650
0.01% 619
2019
Q3
$26K Hold
650
0.01% 636
2019
Q2
$28K Buy
650
+500
+333% +$19.2K 0.01% 605
2019
Q1
$6K Buy
+150
New +$5.73K ﹤0.01% 841

Other funds holding BSX

Investors Research Corp's BSX Position: Q2 2026 in Review

Investors Research Corp opened a new position in Boston Scientific (BSX) in Q2 2026: 300 shares worth $12.8K. The stake represents ﹤0.01% of the portfolio and ranks #512 among its holdings. This is a return to the name: Investors Research Corp previously reported a position in BSX as recently as Q2 2024.

Investors Research Corp first reported a position in BSX in Q1 2019 and has held it in 21 quarters since. The position peaked at $30.1K in Q4 2022. 291 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Investors Research Corp held 300 shares of Boston Scientific worth $12.8K as of Q2 2026.
  • Boston Scientific was a new Investors Research Corp position in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Investors Research Corp's portfolio in Q2 2026, its #512 holding.
  • Investors Research Corp first reported a position in Boston Scientific in Q1 2019 and has held it in 21 quarters since.
  • Investors Research Corp's Boston Scientific position peaked at $30.1K in Q4 2022.
  • 291 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.